BPMCUnknownMid-Cap
Blueprint Medicines Corp Insider Trading Activity
Every SEC Form 4 insider transaction reported for Blueprint Medicines Corp (BPMC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are BPMC insiders buying or selling?
Blueprint Medicines Corp insiders reported no open-market purchases or sales in the last 12 months. Since February 2018, Trabud has recorded 260 Form 4 filings for BPMC: 2 buys ($348.3K) and 258 sells ($143.6M).
Source: SEC EDGAR Form 4
Key Statistics (February 2018 – Jul 8, 2025)
Total Form 4 filings
260
SEC EDGAR
Insider filers
21
Insider buys (2)
$348.3K
Insider sells (258)
$143.6M
Insider sentiment
Net sellingNet insider flow of $143.2M in net selling since February 2018.
Recent BPMC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 1.2K | $128.25 | $150.3K | SEC ↗ |
| Jul 8, 2025 | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale | 1.1K | $128.25 | $134.8K | SEC ↗ |
| Jun 5, 2025 | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale | 2.7K | $127.88 | $340.0K | SEC ↗ |
| May 29, 2025 | Jeffrey W. Albers | Director | Sale | 5.0K | $101.14 | $505.7K | SEC ↗ |
| May 21, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $100.51 | $228.6K | SEC ↗ |
| May 7, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $101.75 | $231.4K | SEC ↗ |
| May 7, 2025 | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale | 2.8K | $103.13 | $283.8K | SEC ↗ |
| Apr 3, 2025 | Kate Haviland | CHIEF EXECUTIVE OFFICER | Sale | 2.5K | $86.65 | $216.5K | SEC ↗ |
| Mar 26, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $95.02 | $216.1K | SEC ↗ |
| Mar 17, 2025 | Jeffrey W. Albers | Director | Sale | 5.8K | $88.80 | $512.0K | SEC ↗ |
| Mar 14, 2025 | Jeffrey W. Albers | Director | Sale | 7.5K | $87.80 | $658.5K | SEC ↗ |
| Mar 7, 2025 | Becker L. Hewes | CHIEF MEDICAL OFFICER | Sale | 10.1K | $88.23 | $890.6K | SEC ↗ |
| Mar 7, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 6.5K | $88.80 | $576.8K | SEC ↗ |
| Mar 7, 2025 | Fouad Namouni | PRESIDENT, R & D | Sale | 6.5K | $88.80 | $576.2K | SEC ↗ |
| Mar 7, 2025 | Tracey L Mccain | EVP AND CHIEF LEGAL OFFICER | Sale | 5.3K | $88.80 | $467.3K | SEC ↗ |
| Mar 7, 2025 | Philina Lee | CHIEF COMMERCIAL OFFICER | Sale | 3.7K | $88.80 | $331.5K | SEC ↗ |
| Mar 7, 2025 | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale | 5.3K | $88.80 | $469.2K | SEC ↗ |
| Mar 7, 2025 | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale | 1.3K | $88.80 | $117.7K | SEC ↗ |
| Mar 7, 2025 | Kate Haviland | CHIEF EXECUTIVE OFFICER | Sale | 16.2K | $88.80 | $1.4M | SEC ↗ |
| Mar 7, 2025 | Debra Durso-Bumpus | CHIEF PEOPLE OFFICER | Sale | 5.2K | $88.80 | $457.9K | SEC ↗ |
| Mar 7, 2025 | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale | 3.5K | $88.80 | $313.5K | SEC ↗ |
| Mar 4, 2025 | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale | 3.2K | $92.62 | $296.7K | SEC ↗ |
| Feb 24, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $95.14 | $216.3K | SEC ↗ |
| Jan 24, 2025 | Kate Haviland | CHIEF EXECUTIVE OFFICER | Sale | 1.4K | $110.24 | $159.4K | SEC ↗ |
| Jan 24, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $110.14 | $250.5K | SEC ↗ |
Showing the 25 most recent of 260 Form 4 filings for Blueprint Medicines Corp.
Most active BPMC insiders
- Jeffrey W. Albers43 filings
- Ariel Hurley42 filings
- Kate Haviland26 filings
- Christina Rossi17 filings
- Becker L. Hewes14 filings
Ask anything about BPMC insider activity
Use Trabud's AI agent to query Blueprint Medicines Corp's Form 4 history in plain English — "Show me BPMC CEO purchases this year" or compare it against any other ticker.
Open the AI agentBPMC insider trading FAQ
Are Blueprint Medicines Corp insiders buying or selling?
Blueprint Medicines Corp insiders reported no open-market purchases or sales in the last 12 months. Since February 2018, Trabud has recorded 260 Form 4 filings for BPMC: 2 buys ($348.3K) and 258 sells ($143.6M). Over the full record that is net selling of $143.2M.
How many insiders trade BPMC stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Blueprint Medicines Corp. The most recent filing was accepted on Jul 8, 2025.
Where does Trabud get BPMC insider trading data?
All BPMC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.